NCF4 (Neutrophil cytosol factor 4) variants and mutations
NCF4 (also known as Neutrophil cytosol factor 4) is a human protein-coding gene encoding a neutrophil cytosol factor 4 protein. It helps organize and regulate phagocyte NADPH oxidase complexes and contributes to reactive-oxygen-species generation in innate immune cells. Biallelic pathogenic variants can cause a milder chronic-granulomatous-disease-like immunodeficiency with recurrent infection and inflammation. This analysis covers 655 NCF4 variants and mutations. Of these, 80% have computational variant effect predictions. Disease context includes chronic granulomatous disease, inflammatory bowel disease, and Crohn disease. Example NCF4 variants include A2T, A2S, and A2G.
Variant analysis overview
- Gene: NCF4
- Protein: Neutrophil cytosol factor 4
- UniProt accession: Q15080
- Organism: Homo sapiens
- Variants analyzed: 655
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 485 unspecified-consequence records; 1 natural variant; 67 missense variants; 77 synonymous variants; 11 frameshift variants; 6 stop-gained variants; 5 splice-region variants; 2 in-frame deletions; 1 splice acceptor variant; 1 in-frame insertions; 1 substitution
- Prediction scores: 525 variants have prediction scores (80% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: chronic granulomatous disease, inflammatory bowel disease, Crohn disease, dermatitis, psoriasis, atopic eczema, asthma, multiple sclerosis, respiratory system disorder, Eczematoid dermatitis, diabetic ketoacidosis, immunodeficiency 86.
Protein structure and variant hotspots
- Protein features: 3 domains; 2 binding sites; 2 post-translational modification sites.
- Structural context: 527 variants have structural context.
- PTM context: 2 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable NCF4 variants
Examples include A2T, A2S, A2G, A2D, A2A, V3E, V3G, V3L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2T (p.Ala2Thr), gnomAD rs1219304314, REVEL 0.05, MetaLR 0.10
- A2S (p.Ala2Ser), gnomAD 22-36861175-G-T, REVEL 0.10, MetaLR 0.04
- A2G (p.Ala2Gly), gnomAD 22-36861176-C-G, REVEL 0.07, MetaLR 0.12
- A2D (p.Ala2Asp), gnomAD 22-36861176-C-A, REVEL 0.07, MetaLR 0.16
- A2A (p.Ala2Ala), gnomAD 22-36861177-T-C, CADD 3.40
- V3E (p.Val3Glu), NCI-TCGA Cosmic COSV9995, cosmic curated COSV99957, Variant assessed as somatic; moderate impact.
- V3G (p.Val3Gly), ExAC rs752307145, gnomAD rs752307145
- V3L (p.Val3Leu), TOPMed rs963395821, REVEL 0.04, MetaLR 0.03
- V3M (p.Val3Met), gnomAD 22-36861178-G-A, REVEL 0.03, MetaLR 0.05
- V3A (p.Val3Ala), gnomAD 22-36861179-T-C, REVEL 0.01, MetaLR 0.08
- V3V (p.Val3Val), gnomAD 22-36861180-G-T, CADD 7.40
- A4T (p.Ala4Thr), TOPMed rs1939766334
- A4S (p.Ala4Ser), gnomAD 22-36861181-G-T, REVEL 0.05, MetaLR 0.05
- A4V (p.Ala4Val), gnomAD 22-36861182-C-T, REVEL 0.03, MetaLR 0.05
- A4D (p.Ala4Asp), gnomAD 22-36861182-C-A, REVEL 0.05, MetaLR 0.04
- A4A (p.Ala4Ala), gnomAD 22-36861183-C-T, CADD 9.46
- Q5* (p.Gln5Ter), TOPMed rs1204019451, gnomAD rs1204019451, CADD 38.00
- Q5R (p.Gln5Arg), gnomAD 22-36861185-A-G, REVEL 0.08, MetaLR 0.03
- Q5H (p.Gln5His), gnomAD 22-36861186-G-T, REVEL 0.04, MetaLR 0.06
- Q5Q (p.Gln5Gln), gnomAD 22-36861186-G-A, CADD 11.90
- Q6* (p.Gln6Ter), gnomAD rs1247533810, CADD 39.00
- Q6K (p.Gln6Lys), gnomAD 22-36861187-C-A, REVEL 0.11, MetaLR 0.15
- Q6R (p.Gln6Arg), gnomAD 22-36861188-A-G, REVEL 0.14, MetaLR 0.15
- Q6H (p.Gln6His), gnomAD 22-36861189-G-T, REVEL 0.10, MetaLR 0.12
- Q6Q (p.Gln6Gln), rs2145696469, gnomAD 22-36861189-G-A, CADD 12.00
- L7L (p.Leu7Leu), gnomAD 22-36861190-C-T, CADD 14.10
- L7P (p.Leu7Pro), gnomAD 22-36861191-T-C, REVEL 0.26, MetaLR 0.16
- R8P (p.Arg8Pro), ExAC rs762576326, TOPMed rs762576326, gnomAD rs762576326, REVEL 0.14, MetaLR 0.10, Uncertain significance
- R8Q (p.Arg8Gln), rs762576326, ClinGen CA10212793, ClinVar RCV002010413, ClinVar RCV005674914, REVEL 0.12, MetaLR 0.10, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- R8W (p.Arg8Trp), rs1488661755, ClinGen CA411374730, ClinVar RCV001374252, TOPMed rs1488661755, REVEL 0.19, MetaLR 0.14, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- R8R (p.Arg8Arg), gnomAD 22-36861193-C-A, CADD 14.80
- A9D (p.Ala9Asp), TOPMed rs1028485815, gnomAD rs1028485815, REVEL 0.04, MetaLR 0.02, Uncertain significance
- A9G (p.Ala9Gly), rs1028485815, ClinGen CA323981153, ClinVar RCV003021710, TOPMed rs1028485815, REVEL 0.04, MetaLR 0.04, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- A9T (p.Ala9Thr), TOPMed rs995268797, gnomAD rs995268797, REVEL 0.03, MetaLR 0.04
- A9P (p.Ala9Pro), gnomAD 22-36861193-CG-C, CADD 32.00
- A9S (p.Ala9Ser), gnomAD 22-36861196-G-T, REVEL 0.04, MetaLR 0.04
- A9A (p.Ala9Ala), rs372612108, gnomAD 22-36861198-C-T, CADD 6.40
- E10K (p.Glu10Lys), rs756372095, ClinGen CA10212796, ClinVar RCV001233497, ExAC rs756372095, REVEL 0.10, MetaLR 0.05, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- E10* (p.Glu10Ter), gnomAD 22-36861199-G-T, CADD 38.00
- E10D (p.Glu10Asp), gnomAD 22-36861201-G-T, REVEL 0.06, MetaLR 0.06
- S11I (p.Ser11Ile), gnomAD rs1425070713, REVEL 0.17, MetaLR 0.11
- S11V (p.Ser11Val), gnomAD 22-36861200-AG-A, CADD 32.00
- S11S (p.Ser11Ser), rs2145702589, gnomAD 22-36864045-T-C, CADD 0.05
- D12E (p.Asp12Glu), ExAC rs766618219, gnomAD rs766618219, REVEL 0.05, MetaLR 0.05
- D12N (p.Asp12Asn), TOPMed rs1447995490, gnomAD rs1447995490, REVEL 0.11, MetaLR 0.08, Uncertain significance, not specified
- F13S (p.Phe13Ser), ExAC rs754276557, gnomAD rs754276557, REVEL 0.31, MetaLR 0.14
- E14D (p.Glu14Asp), gnomAD rs1217111931, REVEL 0.05, MetaLR 0.02
- E14G (p.Glu14Gly), rs2517907766, ClinGen CA411376372, ClinVar RCV003044765, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- E14Q (p.Glu14Gln), gnomAD rs1939855445, REVEL 0.03, MetaLR 0.04
- Q15E (p.Gln15Glu), gnomAD rs1288037973, REVEL 0.21, MetaLR 0.09
- Q15Q (p.Gln15Gln), gnomAD 22-36864057-G-A, CADD 2.77
- L16F (p.Leu16Phe), ExAC rs755356622, TOPMed rs755356622, gnomAD rs755356622, REVEL 0.07, MetaLR 0.08
- P17L (p.Pro17Leu), rs147322774, ClinGen CA10212817, ClinVar RCV000818793, ClinVar RCV004028970, REVEL 0.47, MetaLR 0.17, Uncertain significance, not specified; not provided; Granulomatous disease, chronic, autosomal recessive
- P17P (p.Pro17Pro), rs139289225, gnomAD 22-36864063-G-A, CADD 0.13
- D18G (p.Asp18Gly), gnomAD rs1939856355, REVEL 0.17, MetaLR 0.10
- D18N (p.Asp18Asn), TOPMed rs1939856239
- D18M (p.Asp18Met), rs746841045, gnomAD 22-36864062-CG-C, CADD 0.79
- D19N (p.Asp19Asn), TOPMed rs1046003492, gnomAD rs1046003492, REVEL 0.06, MetaLR 0.04
- D19G (p.Asp19Gly), gnomAD 22-36864068-A-G, REVEL 0.22, MetaLR 0.11
- D19V (p.Asp19Val), gnomAD 22-36864068-A-T, REVEL 0.40, MetaLR 0.18
- D19D (p.Asp19Asp), rs2145702686, gnomAD 22-36864069-T-C, CADD 1.15
- V20D (p.Val20Asp), gnomAD rs1181316793, REVEL 0.37, MetaLR 0.20
- V20I (p.Val20Ile), rs575470394, ClinGen CA10212820, ClinVar RCV001327590, ClinVar RCV004692516, REVEL 0.05, MetaLR 0.04, Uncertain significance, not provided; Granulomatous disease, chronic, autosomal recessive, cytochrome b
- V20V (p.Val20Val), rs1384258034, gnomAD 22-36864072-T-C, CADD 0.53
- A21G (p.Ala21Gly), cosmic curated COSV10456
- A21P (p.Ala21Pro), cosmic curated COSV99957
- A21A (p.Ala21Ala), rs34373276, gnomAD 22-36864075-C-T, CADD 7.49
- I22I (p.Ile22Ile), gnomAD 22-36864078-C-A, CADD 8.19
- S23* (p.Ser23Ter), cosmic curated COSV50621
- S23L (p.Ser23Leu), rs1001835888, ClinGen CA323984523, cosmic curated COSV50621, ClinVar RCV001938696, REVEL 0.14, MetaLR 0.17, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- S23W (p.Ser23Trp), TOPMed rs1001835888, Uncertain significance
- S23S (p.Ser23Ser), rs10854695, gnomAD 22-36864081-G-C, CADD 1.98
- A24G (p.Ala24Gly), TOPMed rs1383416265, gnomAD rs1383416265, REVEL 0.30, MetaLR 0.22
- A24T (p.Ala24Thr), NCI-TCGA Cosmic COSV9995, cosmic curated COSV99957, Variant assessed as somatic; moderate impact.
- A24V (p.Ala24Val), TOPMed rs1383416265, gnomAD rs1383416265
- N25S (p.Asn25Ser), rs573525247, ClinGen CA10212823, ClinVar RCV001923369, ClinVar RCV005443462, REVEL 0.10, MetaLR 0.05, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- N25K (p.Asn25Lys), gnomAD 22-36864087-C-G, REVEL 0.12, MetaLR 0.10
- I26V (p.Ile26Val), 1000Genomes rs541007080, ExAC rs541007080, gnomAD rs541007080, REVEL 0.16, MetaLR 0.15
- I26T (p.Ile26Thr), gnomAD 22-36864089-T-C, REVEL 0.47, MetaLR 0.27
- I26I (p.Ile26Ile), rs139319252, gnomAD 22-36864090-T-C, CADD 5.86
- D28H (p.Asp28His), gnomAD 22-36864092-CTGAC, CADD 33.00
- I29L (p.Ile29Leu), rs1939858000, ClinGen CA411376977, ClinVar RCV002016036, TOPMed rs1939858000, REVEL 0.15, MetaLR 0.14, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- I29M (p.Ile29Met), 1000Genomes rs149998137, ESP rs149998137, ExAC rs149998137, TOPMed rs149998137, Likely benign
- I29N (p.Ile29Asn), 1000Genomes rs13057803, ExAC rs13057803, gnomAD rs13057803, REVEL 0.24, MetaLR 0.16
- I29T (p.Ile29Thr), 1000Genomes rs13057803, ExAC rs13057803, gnomAD rs13057803
- I29V (p.Ile29Val), TOPMed rs1939858000, gnomAD rs1939858000, Uncertain significance
- I29F (p.Ile29Phe), gnomAD 22-36864097-A-T, REVEL 0.23, MetaLR 0.12
- I29I (p.Ile29Ile), rs149998137, gnomAD 22-36864099-C-T, CADD 9.32
- E30K (p.Glu30Lys), rs775229266, ClinGen CA10212830, cosmic curated COSV50620, ClinVar RCV003078933, REVEL 0.39, MetaLR 0.34, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- E30E (p.Glu30Glu), rs200822582, gnomAD 22-36864102-G-A, CADD 8.15
- E31D (p.Glu31Asp), NCI-TCGA Cosmic COSV5062, cosmic curated COSV50621, Variant assessed as somatic; moderate impact.
- E31K (p.Glu31Lys), cosmic curated COSV50623
- E31del (p.Glu31del), rs770609723, gnomAD 22-36864099-CGAG-, CADD 19.40
- E31E (p.Glu31Glu), rs1228095735, gnomAD 22-36864105-G-A, CADD 10.80
- K32E (p.Lys32Glu), rs2145702819, ClinGen CA411377058, ClinVar RCV001987513, Ensembl rs2145702819, AlphaMissense 0.44, MetaLR 0.23, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- K32M (p.Lys32Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K32N (p.Lys32Asn), TOPMed rs1939858619, REVEL 0.25, MetaLR 0.23
- K32K (p.Lys32Lys), rs1939858619, gnomAD 22-36864108-G-A, CADD 10.10
- R33G (p.Arg33Gly), ExAC rs768042374
- R33I (p.Arg33Ile), ExAC rs773949075
- R33K (p.Arg33Lys), ExAC rs773949075, REVEL 0.07, MetaLR 0.03
- R33E (p.Arg33Glu), gnomAD 22-36864103-G-GAG, CADD 30.00
- G34A (p.Gly34Ala), rs766859628, ClinGen CA10212837, ClinVar RCV002958182, ExAC rs766859628, REVEL 0.30, MetaLR 0.29, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- G34D (p.Gly34Asp), ExAC rs766859628, TOPMed rs766859628, gnomAD rs766859628, REVEL 0.36, MetaLR 0.25, Uncertain significance
- G34V (p.Gly34Val), rs766859628, ClinGen CA10212836, ClinVar RCV000794699, ExAC rs766859628, REVEL 0.41, MetaLR 0.25, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- G34L (p.Gly34Leu), gnomAD 22-36864106-AAG-A, CADD 27.50
- G34G (p.Gly34Gly), rs765598164, gnomAD 22-36864114-C-T, CADD 11.90
- F35L (p.Phe35Leu), ExAC rs758660640, gnomAD rs758660640, REVEL 0.32, MetaLR 0.20
- F35S (p.Phe35Ser), cosmic curated COSV50620, ExAC rs764060580, gnomAD rs764060580, REVEL 0.44, MetaLR 0.25
- F35Y (p.Phe35Tyr), ExAC rs764060580, gnomAD rs764060580
- F35F (p.Phe35Phe), rs757314998, gnomAD 22-36864117-C-T, CADD 12.10
- T36I (p.Thr36Ile), rs1939860402, ClinGen CA411377209, ClinVar RCV002636090, ClinVar RCV004827896, REVEL 0.08, MetaLR 0.04, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- T36P (p.Thr36Pro), rs200818199, ClinGen CA10212845, cosmic curated COSV50620, ClinVar RCV000990432, REVEL 0.26, MetaLR 0.14, Likely benign, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- T36S (p.Thr36Ser), gnomAD 22-36864118-A-T, REVEL 0.10, MetaLR 0.03
- T36T (p.Thr36Thr), rs1939860652, gnomAD 22-36864120-C-T, CADD 13.00
- S37G (p.Ser37Gly), 1000Genomes rs199943692
- S37R (p.Ser37Arg), rs1939860899, ClinGen CA411377241, ClinVar RCV001325907, NCI-TCGA TCGA novel, REVEL 0.25, MetaLR 0.11, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- S37S (p.Ser37Ser), gnomAD 22-36864123-C-T, CADD 7.95
- F39S (p.Phe39Ser), gnomAD rs1341984523, REVEL 0.37, MetaLR 0.17
- F39F (p.Phe39Phe), gnomAD 22-36864129-T-C, CADD 11.10
- V40L (p.Val40Leu), Ensembl rs1939887013, REVEL 0.14, MetaLR 0.08
- V40A (p.Val40Ala), gnomAD 22-36864920-T-C, REVEL 0.29, MetaLR 0.19
- F41Y (p.Phe41Tyr), rs1601547189, ClinGen CA411378599, ClinVar RCV000795993, Ensembl rs1601547189, AlphaMissense 0.46, MetaLR 0.06, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- p.Phe41 Val45del, rs1200078508, gnomAD 22-36864916-TAGGT, CADD 24.70
- F41F (p.Phe41Phe), rs369350039, gnomAD 22-36864924-C-T, CADD 5.23
- V42I (p.Val42Ile), ESP rs371578849, ExAC rs371578849, TOPMed rs371578849, gnomAD rs371578849, REVEL 0.14, MetaLR 0.19, Uncertain significance
- V42L (p.Val42Leu), rs371578849, ClinGen CA10212871, ClinVar RCV001238668, ESP rs371578849, REVEL 0.22, MetaLR 0.21, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- V42V (p.Val42Val), rs1424343568, gnomAD 22-36864927-C-A, CADD 7.22
- I43V (p.Ile43Val), ExAC rs779970175, gnomAD rs779970175, REVEL 0.18, MetaLR 0.22
- I43I (p.Ile43Ile), rs753635134, gnomAD 22-36864930-C-T, CADD 4.84
- E44* (p.Glu44Ter), cosmic curated COSV99957
- E44D (p.Glu44Asp), ExAC rs754759226, gnomAD rs754759226, REVEL 0.25, MetaLR 0.25, Likely benign
- E44K (p.Glu44Lys), rs900312893, NCI-TCGA Cosmic COSV9995, TOPMed rs900312893, REVEL 0.25, MetaLR 0.26, Variant assessed as somatic; moderate impact.
- E44Q (p.Glu44Gln), TOPMed rs900312893
- E44A (p.Glu44Ala), gnomAD 22-36864932-A-C, REVEL 0.44, MetaLR 0.33
- V45E (p.Val45Glu), gnomAD 22-36864935-T-A, REVEL 0.68, MetaLR 0.44
- V45V (p.Val45Val), rs1390581384, gnomAD 22-36864936-G-A, CADD 5.90
- K46N (p.Lys46Asn), gnomAD 22-36864939-G-C, REVEL 0.28, MetaLR 0.24
- T47T (p.Thr47Thr), rs1939887697, gnomAD 22-36864942-A-G, CADD 0.34
- G49A (p.Gly49Ala), gnomAD rs1402948199, REVEL 0.30, MetaLR 0.19
- G49R (p.Gly49Arg), rs148715332, ClinGen CA10212875, ClinVar RCV000818749, 1000Genomes rs148715332, REVEL 0.38, MetaLR 0.25, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- G49V (p.Gly49Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G49E (p.Gly49Glu), gnomAD 22-36864947-G-A, REVEL 0.32, MetaLR 0.22
- G50E (p.Gly50Glu), cosmic curated COSV10456
- G50R (p.Gly50Arg), NCI-TCGA Cosmic COSV5062, cosmic curated COSV50620, Variant assessed as somatic; moderate impact.
- S51P (p.Ser51Pro), Ensembl rs1939888127
- S51Y (p.Ser51Tyr), gnomAD 22-36864953-C-A, REVEL 0.30, MetaLR 0.24
- K52E (p.Lys52Glu), TOPMed rs1939888361, gnomAD rs1939888361, REVEL 0.18, MetaLR 0.16
- K52R (p.Lys52Arg), cosmic curated COSV50625
- K52S (p.Lys52Ser), rs1282571591, gnomAD 22-36864952-TCCAA, CADD 32.00
- K52K (p.Lys52Lys), rs1317941283, gnomAD 22-36864957-G-A, CADD 11.10
- Y53H (p.Tyr53His), ExAC rs747769633, gnomAD rs747769633, REVEL 0.35, MetaLR 0.25
- Y53Y (p.Tyr53Tyr), rs1249233393, gnomAD 22-36864960-C-T, CADD 7.83
- Y53* (p.Tyr53Ter), gnomAD 22-36864960-C-G, CADD 36.00
- L54F (p.Leu54Phe), gnomAD rs1338406421, REVEL 0.08, MetaLR 0.09
- L54I (p.Leu54Ile), NCI-TCGA Cosmic COSV9995, cosmic curated COSV99957, Variant assessed as somatic; moderate impact.
- L54L (p.Leu54Leu), gnomAD 22-36864963-C-T, CADD 11.70
- I55S (p.Ile55Ser), TOPMed rs932330052, gnomAD rs932330052, REVEL 0.56, MetaLR 0.30, Uncertain significance
- I55T (p.Ile55Thr), rs932330052, ClinGen CA323985668, ClinVar RCV001926078, TOPMed rs932330052, REVEL 0.50, MetaLR 0.30, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- I55V (p.Ile55Val), cosmic curated COSV50629
- I55L (p.Ile55Leu), gnomAD 22-36864964-A-C, REVEL 0.34, MetaLR 0.18
- Y56C (p.Tyr56Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y56Y (p.Tyr56Tyr), gnomAD 22-36864969-C-T, CADD 9.05
- Y56* (p.Tyr56Ter), gnomAD 22-36864969-C-G, CADD 37.00
- R57C (p.Arg57Cys), ExAC rs767200492, TOPMed rs767200492, gnomAD rs767200492, REVEL 0.69, MetaLR 0.54
- R57H (p.Arg57His), rs746353194, ClinGen CA411379023, cosmic curated COSV50623, ClinVar RCV001943111, REVEL 0.59, MetaLR 0.52, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- R57L (p.Arg57Leu), rs746353194, ClinGen CA10212879, ClinVar RCV001058342, ExAC rs746353194, REVEL 0.66, MetaLR 0.56, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- R57P (p.Arg57Pro), ExAC rs746353194, TOPMed rs746353194, gnomAD rs746353194, REVEL 0.71, MetaLR 0.56, Uncertain significance
- R57R (p.Arg57Arg), gnomAD 22-36864972-C-T, CADD 11.50
- R58C (p.Arg58Cys), rs143532979, ClinGen CA10212881, cosmic curated COSV50624, ClinVar RCV000595538, REVEL 0.48, MetaLR 0.37, Conflicting interpretations, not specified; Granulomatous disease, chronic, autosomal recessive, cytochrome b
- R58G (p.Arg58Gly), 1000Genomes rs143532979, ExAC rs143532979, TOPMed rs143532979, gnomAD rs143532979, Benign
- R58H (p.Arg58His), rs763314327, ClinGen CA10212882, NCI-TCGA Cosmic COSV5062, cosmic curated COSV50620, REVEL 0.54, MetaLR 0.49, Uncertain significance, not specified; not provided
- p.Arg58 Arg60del, rs1939888887, gnomAD 22-36864965-TCTAC, CADD 21.20
- Y59* (p.Tyr59Ter), gnomAD 22-36864978-C-A, CADD 38.00
- R60C (p.Arg60Cys), rs183179978, ClinGen CA10212883, cosmic curated COSV50622, ClinVar RCV001246430, REVEL 0.33, MetaLR 0.29, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- R60H (p.Arg60His), rs369847561, ClinGen CA10212884, cosmic curated COSV50620, NCI-TCGA Cosmic COSV5062, REVEL 0.25, MetaLR 0.27, Uncertain significance, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- R60L (p.Arg60Leu), cosmic curated COSV50627, REVEL 0.28, MetaLR 0.29
- R60R (p.Arg60Arg), rs762003847, gnomAD 22-36864981-C-T, CADD 11.60
- H63R (p.His63Arg), ExAC rs767668921, gnomAD rs767668921, REVEL 0.15, MetaLR 0.08
- H63Y (p.His63Tyr), Ensembl rs1939889963, REVEL 0.05, MetaLR 0.03
Public NCF4 analysis runs
- NCF4 analysis run — NCF4 (655 variants) — completed 2026-08-22